Investigational new drugs for the treatment of acute coronary syndrome.

about

Investigational new drugs for the treatment of acute coronary syndrome.

Item

http://www.wikidata.org/entity/Q38594609

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Investigational new drugs for the treatment of acute coronary syndrome.

@en

type

Item

label

Investigational new drugs for the treatment of acute coronary syndrome.

@en

prefLabel

Investigational new drugs for the treatment of acute coronary syndrome.

@en

P1476

Investigational new drugs for the treatment of acute coronary syndrome.

@en

P2093

Bryan P Yan

http://www.w3.org/2001/XMLSchema#string

Cormac T O'Connor

http://www.w3.org/2001/XMLSchema#string

Thomas J Kiernan

http://www.w3.org/2001/XMLSchema#string

P2860

2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice.

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Platelet-collagen interaction: is GPVI the central receptor?

Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit

P304

1557-1570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2015.1094459

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26414862

http://www.w3.org/2001/XMLSchema#string